Wisenheimer Posted - 1 day ago

$DMAC probably back below 2 - more delays and started off call w how good Kal is doing in China - that was the only positive even though its their commodity competitor - they will need to raise funds again ughhhhh!

epsguid Posted - 1 day ago

$DMAC reported a loss of $0.14, consensus was ($0.16) via @eWhispers #epsbeat http://eps.sh/d/dmac

Stock_Titan Posted - 1 day ago

$DMAC DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results https://www.stocktitan.net/news/DMAC/dia-medica-therapeutics-provides-a-business-update-and-announces-tgvhigm13ptf.html

gillyduzit Posted - 3 days ago

$DMAC fine I'll share with the team

Sukitt Posted - 6 days ago

$DMAC If anyone has an insert for the human urinary kallidinogenase (Kalikang?), please post a link. Thank you ahead of time. There was a site through either Shanghai Pharma or Foshun pharma in the past with an image, but nothing with details like indication, pharmacokinetics, adverse reactions (pre/post marketing), etc. Regards.

Sicksir Posted - 6 days ago

$DMAC we’re so back baby 🍆

MedCred Posted - 1 week ago

$DMAC earnings and update earlier this time 7 weeks after last one in latter part of March. Somethings up !!!!!!!!???!!!!!!

Stock_Titan Posted - 1 week ago

$DMAC DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024 https://www.stocktitan.net/news/DMAC/dia-medica-therapeutics-to-report-first-quarter-2024-financial-853lwx9z6ifj.html

MedCred Posted - 04/26/24

$DMAC Eight sites up and running as of this afternoon Per clinical trials.gov Two new sites today online. Things are speeding up.

DonCorleone77 Posted - 04/17/24

$DMAC DiaMedica Therapeutics says first patient dosed in relaunch of DM199 trial The company states: "DiaMedica Therapeutics announced the first patient being dosed in DiaMedica's relaunch of its pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the treatment of acute ischemic stroke. The company continues to work closely with its contract research organization, on re-engaging with study sites for the ReMEDy2 Trial. The trial is intended to enroll approximately 350 patients at up to 100 sites globally. The majority of the U.S. sites are expected to be activated by the end of the third quarter of 2024. With the support of the Canadian Stroke Consortium, the activation of study sites in Canada is expected to begin in the third quarter of 2024. In Australia, the Company has received provisional endorsement from the Australian Stroke Trials Network and Australian site activation is expected to commence in the fourth quarter of 2024. Initial steps are also being taken to expand ReMEDy2 into the United Kingdom, Spain, and select other European countries."

Stock_Titan Posted - 04/17/24

$DMAC DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke https://www.stocktitan.net/news/DMAC/dia-medica-therapeutics-announces-first-patient-dosed-in-relaunch-of-02pirecybo18.html

Thestocktraderhubzee Posted - 03/22/24

WATCHLIST MAR 22 2024 $OLLI Truist Securities Maintains Hold on Ollie's Bargain Outlet, Raises Price Target to $80 $DMAC Craig-Hallum Maintains Buy on DiaMedica Therapeutics, Lowers Price Target to $8 $FIVE Craig-Hallum Maintains Hold on Five Below, Lowers Price Target to $187 $SUI Compass Point Maintains Neutral on Sun Communities, Raises Price Target to $125 $BNTX BMO Capital Maintains Outperform on BioNTech, Lowers Price Target to $123

DonCorleone77 Posted - 03/21/24

$DMAC DiaMedica Therapeutics files $100M mixed securities shelf

Tjcmd Posted - 03/21/24

$DMAC $100,000,000 shelf offering filed

AnaChart Posted - 03/21/24

$DMAC https://anachart.com/wp-content/uploads/ana_temp/1711047746_soc-img.jpg

AnaChart Posted - 03/21/24

$DMAC https://anachart.com/wp-content/uploads/ana_temp/1711026100_soc-img.jpg

Wisenheimer Posted - 03/20/24

$DMAC and pushed out timeline ughh

Wisenheimer Posted - 03/20/24

$DMAC

epsguid Posted - 03/19/24

$DMAC reported a loss of $0.14, consensus was ($0.14) via @eWhispers #epsmeet http://eps.sh/d/dmac

Sukitt Posted - 03/15/24

$DMAC Today's 1 month chart looks like a middle finger. Still~>

Tjcmd Posted - 2 months ago

$DMAC this drug (derived from urine) has been used for over 20 years in Asia and is SOC. IMO there is absolutely no reason that this synthetic version won’t be efficacious. The unfortunate issue with the IV bags absorbing the drug is an opportunity to get a game changing treatment for acute ischemic stroke at bargain basement pricing…

Doozio Posted - 2 months ago

$DMAC 🧠⏰♾️

Doozio Posted - 2 months ago

$DMAC a 🧠👀 is now chop chop huckleberries 🧠⏰

MedCred Posted - 02/29/24

$DMAC now up to 6 sites recruiting Another one on board today. Per clinical trials.gov.

MedCred Posted - 02/27/24

$DMAC five sites now recruiting.. university of Pennsylvania now up and running. Per clinical trials.gov

Viter Posted - 02/20/24

$DMAC Arkansas Locations Fayetteville, Arkansas, United States, 72703 Terminated Washington Regional Medical Center

Mufasha Posted - 3 months ago

$DMAC 10$ by EOY

Sukitt Posted - 3 months ago

$DMAC For the product

JaydenBest Posted - 3 months ago

$DMAC $BATL $APLD Analyst price target for today<. https://live-alerts-stock-trades.topmarketwatch.vip

Sicksir Posted - 3 months ago

$DMAC Let’s go DMAC!